Amphotericin B as antiviral drug: Possible efficacy against COVID-19

Amphotericin B as antiviral drug: Possible efficacy against COVID-19

Since its discovery, amphotericin B (AmB) is still one of the most common first-line choices in treatment pulmonary mycoses for over seventh decades from discovery. AmB which is belonged to the polyene group has a wide spectrum in vitro and in vivo antimicrobial activity against fungi and parasites,...

Full description

Bibliographic Details
Main Author: Falah Hasan Obayes AL-Khikani
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Annals of Thoracic Medicine
Subjects:
amphotericin b
antimicrobial agents
antiviral drugs
coronavirus
covid-19
Online Access:http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2020;volume=15;issue=3;spage=118;epage=124;aulast=AL-Khikani

Internet

http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2020;volume=15;issue=3;spage=118;epage=124;aulast=AL-Khikani

Similar Items